The largest database of trusted experimental protocols

Xterra rp c18 column

Manufactured by Waters Corporation
Sourced in United States

The XTerra RP C18 column is a reversed-phase high-performance liquid chromatography (HPLC) column. It is designed for the separation and analysis of a wide range of compounds, including polar and non-polar molecules. The column features a silica-based stationary phase with octadecylsilane (C18) bonded ligands, which provide efficient and selective separation capabilities.

Automatically generated - may contain errors

9 protocols using xterra rp c18 column

1

Enzymatic Conversion of Bile Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
All bioconversions were carried out employing 1 Utot of purified Sm7α‐HSDS and 0.6 Utot of purified 7β‐HSDS on 10 mm (if not differently specified) of CDCA or CA, NAD+ (0.2, 0.5, or 1.0 mm). As a general procedure, 1 mL of reaction mixture containing 10 % MeOH and 50 mm KPi buffer, pH 8.0, was incubated at 25 °C: at fixed times, 50 μL of reaction mixture were withdrawn, diluted with 250 μL of MeOH and centrifuged at 14 000 g for 2 min. 10 μL of the obtained samples were analyzed by HPLC. HPLC analyses were performed on a Shimadzu (Kyoto, Japan) apparatus equipped with a LC20AT pump and an ELSD‐LTII detector and fitted with a XTerra RP C18 column (Waters, Milford, US) (length/internal diameter 150/4.6 mm, pore size 5 μm) under the following conditions: for analyses of CA, 7‐oxo‐DCA and UCA, eluent: H2O/CH3CN/TFA (70:30:0.1), flow 1.0 mL min−1. Retention times CA=6.75 min, 7‐oxo‐DCA=4.82 min, UCA=4.03 min. For analyses of CDCA, 7‐oxo‐LCA and UDCA, eluent: H2O/CH3CN/TFA (65:35:0.1), flow 1.0 mL min−1. Retention times CDCA=4.11 min, 7‐oxo‐LCA=3.49 min, UDCA=3.21 min.
+ Open protocol
+ Expand
2

HPLC Quantification of Lopinavir

Check if the same lab product or an alternative is used in the 5 most similar protocols
An Agilent 1260 Infinity series HPLC (Agilent Technologies, Santa Clara, CA) equipped with a Waters XTerra RP C-18 column (150 mm × 4.6 mm, i.d. 3.5 μm) (Waters Corp., Milford, MA) was used. An isocratic elution method of 60% acetonitrile and 40% water was used. LPV was detected at 210 nm with an injection volume of 50 μL and a flow rate of 1 mL/min. The total run length was 7 min. Standard curves covering the concentration ranges of 1-19 μg/mL and 0.1-1 μg/mL were used.
+ Open protocol
+ Expand
3

Quantitative HPLC Analysis of Oxaliplatin Release

Check if the same lab product or an alternative is used in the 5 most similar protocols
HPLC analysis was performed using an Agilent 1200 Infinity Series HPLC system (Agilent Technologies, Waldbronn, Germany) to determine the % EE and in vitro oxaliplatin release from MVLs. Briefly, after necessary dilution with the mobile phase, 20 μL of each sample was injected by using an autosampler (Model 1260 ALS, Agilent Technologies, Waldbronn, Germany). The chromatographic analyses were performed through a XTerra™ RPC18 column (Waters, Milford, MA, USA; 300 × 3.9 × 5 μm) and detected at 254 nm using an HPLC-UV spectrometer (Agilent 1290 Infinity, Agilent Technologies, Waldbronn, Germany). The mobile phase consisted of a 30:70 (v/v) mixture of MeOH and 5-mM sodium-1 heptane sulfonate in water. A flow rate of 1 mL/min of the mobile phase (Model 1260 Quat Pump VL, Agilent Technologies, Waldbronn, Germany) was used.
+ Open protocol
+ Expand
4

HPLC-Based Oxaliplatin Release and Encapsulation Efficiency

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro oxaliplatin release and % EE were determined by using HPLC Agilent 1200 Infinity Series HPLC system (Agilent Technologies, Waldbronn, Germany). Briefly, XTerra™ RPC18 column (particle size 5 μm, inside diameter 4.6 mm, and length 250 mm; Waters Corporation, Milford, MA, USA) at 210 nm using an HPLC-UV spectrometer (Agilent 1290 infinity). The mobile phase was a 20:80 mixture of ACN and deionized water and was set to a flow rate of 0.8 mL/min (Model 1260 Quat Pump VL). The samples were diluted as necessary, and 20 μL of each sample was injected using an autosampler (Model 1260 ALS).2.9. Statistical Analysis
In vitro percent (%) cumulative oxaliplatin release and in vivo pharmacokinetic study data are expressed as the means ± standard deviations. The t-test or two-sided RM ANOVA and Bonferroni test were applied to the analyses of the differences between the groups. A p value < 0.05 was considered as a statistically significant difference.
+ Open protocol
+ Expand
5

HPLC-MS Targeted Phenolic Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The same HPLC-mass spectrometry system mentioned above was used in the targeted phenolic compound detection, and this time an Xterra RP-C18 column (Waters Corporation, Milford, MA, USA) with the dimensions of 3.9 × 100 mm and a particle size of 3.5 μm was used for optimal separation. Extracted bacterial samples were injected into the column for gradient elution separation at 0.900 mL/min using solvents A (89.9% water/10% acetonitrile/0.1% formic acid, v/v/v) and B (69.9% water/30% acetonitrile/0.1% formic acid, v/v/v). The autosampler temperature was kept at 4 °C, the column compartment was set at 30 °C, and the separation time for each sample was 11 min. The retention time and selected reaction monitoring (SRM) transitions of targeted metabolites and polyphenols (or compound pairs) were established by running pure standards and collecting the MS/MS data, and therefore, the orthogonal information on the retention time and two pairs of SRM transitions can be used to confidently detect and identify phenolic compounds. When biological samples were run, pooled polyphenol standards as quality controls were also tested in between every 10 samples to monitor the instrument stability.
+ Open protocol
+ Expand
6

Quantitative Serotonin Extraction from Plant Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serotonin content was detected as published method (Jin et al., 2015). 200 mg leaf tissue at the heading stage was ground with liquid nitrogen into a powder and soaked in 1 mL 100% methanol. The homogenates were centrifuged at 12 000 g for 30 min and the supernatant was filtered through a syringe with a 0.22 μm PVDF membrane (Millipore). Then the filtrate was evaporated to dryness under refrigerating vacuum pump and dissolved in 500 μL 50% methanol. The samples were separated on an XTerra RP C18 column (250 × 4.6 mm, 5 μm, Waters) with an isocratic elution of 50% methanol in water containing 0.3% trifluoroacetic acid at a flow rate of 0.4 mL/min. A UV wavelength of 280 nm was used for detection.
+ Open protocol
+ Expand
7

Quantification of Tryptophan and Serotonin

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each sample, 100 mg leaf tissue was ground with liquid nitrogen into a powder and soaked in 2 ml 100% methanol. The homogenates were centrifuged at 10,000 × g for 10 min and the supernatant was filtered through a syringe with a 0.2 μm cellulose acetate membrane filter (Pall, USA). Then the filtrate was evaporated to dryness under vacuum and dissolved in 500 μl 50% methanol. The final sample was analyzed by reversed-phase HPLC (Waters, USA) so that the tryptophan and serotonin contents could be quantified. The samples were separated on an XTerra RP C18 column (250 × 4.6 mm, 5 μm, Waters) with an isocratic elution of 50% methanol in water containing 0.3% trifluoroacetic acid at a flow rate of 0.4 ml/min. A UV wavelength of 280 nm was used for detection. The standard samples for tryptophan and serotonin were made by Sigma (USA).
+ Open protocol
+ Expand
8

Quantification of Thiamine Stability

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chemical stability of thiamine in solution was measured in accordance with an adaptation of AOAC method 942.23 for quantification of thiamine [29 ]. Reverse-phase HPLC (Waters Corp. Milford, MA) using a gradient method with 0.1% TFA in water (v/v) and acetonitrile as the mobile phases, A and B, respectively, was used in accordance with our previous study [16 (link)]. Briefly, a Waters 2690 Separations Module and a Waters 2996 Photodiode Array (PDA) detector were used with a Waters XTerra RP-C18 column and a wavelength scan of 235–400 nm. The gradient method was as follows: 100/0 at 0 min, 97/3 at 4 min (linear), 90/10 at 6 min (linear), 100/0 at 10 min (linear), and 100/0 at 15 min. Prior to analysis, solutions were cooled in an ice bath, and diluted with the 0.1% TFA in water mobile phase to an estimated thiamine concentration of 500 ppm, or 0.5 mg/mL (assuming no degradation). Standard curves of TMN and TClHCl (R2 > 0.999) were prepared using the area under the analyte peak to calculate thiamine concentration of samples on each day of analysis using a concentration range of 10 ppm to 1000 ppm. Integration of the analyte peak was performed at 254 nm.
+ Open protocol
+ Expand
9

Quantifying Theophylline Content in Polymer Filaments

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine changes in the drug contents of the filament after storage, 120 mg of the Eudragit EPO and RL, HPC.SSL and PVP-based filaments containing theophylline were solubilised in 0.1 M HCl and sonicated for 2h or 8 h (for Eudragit RL-based filament only). The API was measured by HPLC using an Agilent UV-HPLC 1260 series (Agilent Technologies, Inc., Germany) and an XTerra RP C18 column (150 × 4.6 mm, 5 μm particle size) (Waters, Ireland). A mobile phase of 10 mM solution of ammonium acetate buffer, methanol and acetonitrile at volume ratio of 86:7:7. Analysis was carried out at a wavelength of 272 nm, column temperature of 40 o C, flow rate of 1 mL/min, injection volume was 5 µL and a run time of 7 min as reported previously (Okwuosa et al. 2016 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!